Manufacturer record

Bonn Schetering Bio Sciences: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Bonn Schetering Bio Sciences (Puducherry) were declared Not of Standard Quality between November 2024 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: MVO-070, Ttocin Ointment, Mupirocin with Tea Tree Oil Ointment (exp Sep 2026). DTL Chennai (state lab) found it not of standard quality: Sample does not conform to label claim with respect to the content of mupirocin. Listed in the January 2025 alert.

Records by type

2 records linked to Bonn Schetering Bio Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2024 to Jan 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
2
Products affected
Labelling
Most common failure
Jan 2025
Latest alert

Flagged batches per year

2024 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ttocin Ointment, Mupirocin with Tea Tree Oil Ointment Batch MVO-070Mfg Oct 2024 · Exp Sep 2026 Sample does not conform to label claim with respect to the content of mupirocin.Labelling DTL ChennaiState lab Jan 2025
Lox Cv Dry Syrup Batch MVDS-032Mfg Aug 2024 · Exp Jan 2026 Sample does not conform to IP specification for Amoxycillin and potassium Clavulanate oral suspension with respect to the content of Amoxycillinin AmoxycillinTrihydrate.Other DTL ChennaiState lab Nov 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.